Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

Pharmaceutical

Enalare Therapeutics

Herm Cukier

Alfred Schweikert Ph.D., Rac

Robert Raffa

Marty Lutz

Alfred Schweikert

Joseph Pergolizzi

Frank Diana

Thomas Miller

Daniel Motto

The leadership team at Enalare Therapeutics has a history of experience in the biotech and pharmaceutical industries, as well as in marketing and international business. The team's education histories include degrees in biochemistry, microbiology, immunology, and bioengineering from universities such as the University of Tennessee Health Science Center, West Virginia University, and the University of Pennsylvania.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Enalare Therapeutics

Board of Directors

CEO and Executive Team